Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Surgical.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2018-02-20 GNMK MASSARANY HANY (President and CEO, Director) S -6,584 881,758 -0.74 4.37 -28,772 3,853,282 -0.75
2018-02-20 GNMK Gleeson Michael (SVP, North American Com. Ops.) S -2,134 286,638 -0.74 4.37 -9,326 1,252,608 -0.74
2018-02-20 GNMK Mendel Scott (Chief Financial Officer) S -2,304 217,619 -1.05 4.37 -10,068 950,995 -1.06
2018-02-20 GNMK Williams Jennifer Anne (SVP, Human Resources) S -2,177 149,342 -1.44 4.37 -9,513 652,625 -1.46
2018-02-20 GNMK Stier Eric (SVP & General Counsel) S -1,996 132,112 -1.49 4.37 -8,723 577,329 -1.51
2018-02-20 NURO Gozani Shai (President & CEO, Director) P 1,000 73,696 1.38 1.3634 1,363 100,477 1.36
2018-02-20 NURO HIGGINS THOMAS T (Senior Vice President, CFO) P 1,500 32,463 4.84 1.36 2,040 44,150 4.62
2018-02-19 CRY Matthews William Robert (Senior VP, Operations, Quality) F -1,183 35,117 -3.26 18.25 -21,590
2018-02-19 CRY Mackin James P (President & CEO) F -3,049 313,400 -0.96 18.25 -55,644
2018-02-19 CRY Mackin James P (President & CEO) F -4,591 308,809 -1.46 18.25 -83,786
2018-02-19 CRY LEE DAVID ASHLEY (Executive VP, COO & CFO) F -1,375 296,274 -0.46 18.25 -25,094
2018-02-19 CRY LEE DAVID ASHLEY (Executive VP, COO & CFO) F -1,413 294,861 -0.48 18.25 -25,787
2018-02-19 CRY Horton Amy (VP, Chief Accounting Officer) F -569 96,636 -0.59 18.25 -10,384
2018-02-19 CRY Horton Amy (VP, Chief Accounting Officer) F -933 95,703 -0.97 18.25 -17,027
2018-02-19 CRY Holloway Jean F (VP, General Counsel) F -836 47,858 -1.72 18.25 -15,257
2018-02-19 CRY Holloway Jean F (VP, General Counsel) F -1,041 46,817 -2.18 18.25 -18,998
2018-02-19 CRY Davis John E (Senior VP, Global Sales) F -1,183 39,708 -2.89 18.25 -21,590
2018-02-19 CRY Capps Scott B (VP, Clinical Research) F -726 134,868 -0.54 18.25 -13,250
2018-02-19 CRY Capps Scott B (VP, Clinical Research) F -795 134,073 -0.59 18.25 -14,509
2018-02-19 CRY Capps Scott B (VP, Clinical Research) F -2,246 131,827 -1.68 18.25 -40,990
2018-02-19 CRY Mackin James P (President & CEO) F -9,527 299,282 -3.09 18.25 -173,868
2018-02-19 CRY LEE DAVID ASHLEY (Executive VP, COO & CFO) F -3,744 291,117 -1.27 18.25 -68,328
2018-02-19 CRY Horton Amy (VP, Chief Accounting Officer) F -1,480 94,223 -1.55 18.25 -27,010
2018-02-19 BAX Mason Jeanne K (SVP, Human Resources) A 4,697 95,973 5.15
2018-02-19 BAX Mason Jeanne K (SVP, Human Resources) A 3,507 99,480 3.65
2018-02-19 BAX Martin Sean (SVP and General Counsel) A 4,007 24,209 19.83
2018-02-19 BAX ALMEIDA JOSE E (Chairman, CEO and President, Director) A 36,389 90,715 66.98
2018-02-19 BAX ALMEIDA JOSE E (Chairman, CEO and President, Director) A 25,054 115,769 27.62
2018-02-19 BAX SACCARO JAMES (Executive VP and CFO) A 8,453 127,331 7.11
2018-02-19 BAX SACCARO JAMES (Executive VP and CFO) A 5,511 132,842 4.33
2018-02-19 BAX Pleau Scott (SVP, Operations) A 2,004 20,121 11.06
2018-02-19 BAX Karp Caroline (SVP, Controller) A 374 12,016 3.21
2018-02-19 BAX Eyre Brik V (SVP, President, Americas) A 7,044 78,198 9.90
2018-02-19 BAX Eyre Brik V (SVP, President, Americas) A 5,010 83,208 6.41
2018-02-19 BAX Accogli Giuseppe (SVP, President, Global Bus.) A 879 46,715 1.92
2018-02-19 BAX Accogli Giuseppe (SVP, President, Global Bus.) A 4,383 51,098 9.38
2018-02-16 OSUR SMITH BRIAN (EVP & BU Lead - Molecular) M 10,000 28,075 55.33 5.959 59,590
2018-02-16 RMD Hollingshead James (President, Sleep Business) F -862 61,140 -1.39 93.81 -80,864
2018-02-16 BEAT Wisniewski Daniel (SVP, Technical Operations) F -4,939 26,291 -15.81 33.67 -166,296
2018-02-16 BEAT Broadway Fred (President BioTel Heart) F -4,175 24,880 -14.37 33.67 -140,572
2018-02-16 BEAT Getz Heather C (Executive VP & CFO) F -7,861 44,156 -15.11 33.67 -264,680
2018-02-16 BEAT Ferola Peter (SVP & General Counsel) F -5,067 24,510 -17.13 33.67 -170,606
2018-02-16 BEAT Capper Joseph H (President & CEO, Director) F -30,923 178,355 -14.78 33.67 -1,041,177
2018-02-16 PEN Davis Daniel Donen (See Remarks) A 10,190 31,809 47.13 98.20 1,000,658
2018-02-16 PEN Wilder Thomas (Director) A 1,215 3,628 50.35
2018-02-16 PEN O'Rourke Bridget (Director) A 1,215 3,150 62.79
2018-02-16 PEN Kassing Don W. (Director) A 1,215 11,163 12.21
2018-02-16 PEN Grewal Harpreet (Director) A 1,215 15,802 8.33
2018-02-16 RVP SHAW THOMAS J (President and CEO, Director, 10% Owner) P 11,612 17,577,335 0.07 0.8747 10,157 15,374,895 0.07
2018-02-16 UTMD PAYNE BARBARA A (Director) S -1,000 28,838 -3.35 90.7 -90,700 2,615,607 -3.47
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)